Portfolio company
Dendreon
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company manufactures autologous cellular immunotherapy for prostate cancer patients and provides end-to-end manufacturing services for the cellular therapy market.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Cellares
This company provides automated manufacturing platforms and services for cell therapy development to biopharmaceutical organisations and academic research centres.
PharmaCell
The company provides contract manufacturing and development services for cell and gene therapy products to pharmaceutical and biotechnology clients.
Bioinvent International
This company develops antibody-based immunotherapies for cancer patients and provides contract manufacturing services to pharmaceutical firms and academic institutions.
Serán
This company provides drug product development, formulation and manufacturing services to pharmaceutical and biotechnology clients.
Abzena
This company provides discovery, development and manufacturing services for biologics and bioconjugates to biotechnology and pharmaceutical customers.
AdThera
The company provides process development and manufacturing services for cell and gene therapies to biotechnology firms and academic centres.
Ascend Advanced Therapies
The company provides development and manufacturing services for gene therapy products to life science innovators and pharmaceutical businesses.
AmplifyBio
This company provides contract research and manufacturing services for cell and gene therapy developers to accelerate drug discovery and clinical development.
